MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-13-2026
Aziyo Biologics General and Administrative Expenses 2011-2026 | AZYO
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses Aziyo Biologics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 15.1 M | 18.1 M | 14.1 M | 16.1 M | 13.7 M | 13.2 M | 9.62 M | 8.52 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 18.1 M | 8.52 M | 13.5 M |
Quarterly General and Administrative Expenses Aziyo Biologics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.52 M | 3.7 M | 3.87 M | 4.34 M | 4.69 M | 5.06 M | 2.76 M | 3.86 M | 3.52 M | - | 4.33 M | 4.71 M | 4.02 M | - | 3.52 M | 3.53 M | 3.6 M | - | 2.67 M | 2.08 M | 2.61 M | - | 2.45 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.06 M | 2.08 M | 3.62 M |
General and Administrative Expenses of other stocks in the Medical devices industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
499 M | $ 11.69 | -3.79 % | $ 1.75 B |  USA |
 |
Butterfly Network
BFLY
|
39.8 M | $ 4.22 | 0.6 % | $ 893 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
25.6 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
40.2 M | - | - | $ 3.31 B | USA |
 |
Acutus Medical
AFIB
|
14.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
7.11 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
8.78 M | - | -5.86 % | $ 30.6 M | USA |
 |
BioSig Technologies
BSGM
|
11.6 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
28.8 M | - | - | $ 16.4 M | USA |
 |
Inogen
INGN
|
67.4 M | $ 6.22 | -3.57 % | $ 165 M | USA |
 |
Cardiovascular Systems
CSII
|
171 M | - | 0.15 % | $ 844 M | USA |
 |
IRIDEX Corporation
IRIX
|
8.75 M | $ 1.36 | 0.37 % | $ 21.9 M | USA |
 |
Integer Holdings Corporation
ITGR
|
212 M | $ 84.52 | -0.96 % | $ 2.94 B | USA |
 |
Apollo Endosurgery
APEN
|
20.6 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
14.1 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
141 M | - | -4.14 % | $ 702 M | USA |
 |
AxoGen
AXGN
|
44.6 M | $ 31.8 | 0.14 % | $ 1.46 B | USA |
 |
CONMED Corporation
CNMD
|
132 M | $ 36.27 | -0.98 % | $ 1.13 B | USA |
 |
LivaNova PLC
LIVN
|
549 M | $ 62.84 | -0.63 % | $ 3.43 B |  Britain |
 |
Soliton, Inc.
SOLY
|
8.46 M | - | -1.42 % | $ 435 M | USA |
 |
LENSAR
LNSR
|
26.5 M | $ 5.92 | -2.47 % | $ 68.2 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
4.88 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
8.5 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Electromed
ELMD
|
39.3 M | $ 24.12 | -1.51 % | $ 204 M | USA |
 |
Misonix, Inc.
MSON
|
18 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
14.7 M | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
98.6 M | - | - | $ 955 M | USA |
 |
Medtronic PLC
MDT
|
10.8 B | $ 87.16 | -0.06 % | $ 112 B | USA |
 |
Cytosorbents Corporation
CTSO
|
35 M | $ 0.67 | -0.53 % | $ 36.5 M | USA |
 |
Aethlon Medical
AEMD
|
3.24 M | $ 2.24 | -2.61 % | $ 3.5 M | USA |
 |
BIOLASE
BIOL
|
10.2 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
382 M | $ 10.91 | 5.21 % | $ 1.47 B | USA |
 |
Myomo
MYO
|
14 M | $ 0.71 | 0.94 % | $ 29.7 M | USA |
 |
IRadimed Corporation
IRMD
|
17.8 M | $ 99.21 | 0.01 % | $ 1.26 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
22.5 M | $ 2.36 | -3.48 % | $ 138 M | Israel |
 |
Invacare Corporation
IVC
|
227 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
5.9 M | $ 3.81 | 2.14 % | $ 142 M |  France |
 |
OrthoPediatrics Corp.
KIDS
|
120 M | $ 16.28 | -1.15 % | $ 382 M | USA |
 |
Orthofix Medical
OFIX
|
554 M | $ 11.8 | -0.59 % | $ 467 M |  Curacao |
 |
Outset Medical
OM
|
37.9 M | $ 3.47 | -4.15 % | $ 52.8 K | USA |
 |
Inspire Medical Systems
INSP
|
625 M | $ 51.34 | -1.67 % | $ 1.51 B | USA |
 |
Penumbra
PEN
|
663 M | $ 334.62 | -0.29 % | $ 13 B | USA |
 |
Pulmonx Corporation
LUNG
|
101 M | $ 1.39 | -0.36 % | $ 56.6 M | USA |
 |
Cutera
CUTR
|
63.3 M | - | -10.19 % | $ 1.99 M | USA |
 |
Insulet Corporation
PODD
|
1.16 B | $ 225.08 | -0.88 % | $ 15.8 B | USA |
 |
Profound Medical Corp.
PROF
|
10.3 M | $ 5.22 | -3.33 % | $ 180 M | Canada |
 |
Dynatronics Corporation
DYNT
|
8.46 M | - | 14.99 % | $ 929 K | USA |